Pfizer's $3.5 billion cost-savings drive has made its way overseas. After job cuts hit several sites in the U.S., the pharma giant is reducing the headcount at one of its Irish manufacturing plants in Newbridge, Kildare, by 100 employees. The staffers worked on production of Pfizer's COVID-19 antiviral Paxlovid, the company confirmed in an emailed statement. "Onsite operations were expanded in 2021 to meet pandemic needs but, considering the lower-than-expected utilization for our COVID-19 products, production is now scaling down in line with customer demand," a spokesperson said. While the company anticipates "further changes" through its "wider realignment program," Pfizer forecasts overall growth in its Irish manufacturing operations through 2024. For one, 230 new roles will be added between Pfizer's sites in Grange Castle, Dublin, and Ringaskiddy, Cork, RTÉ reports.